An Interview With... Hélène Pora, Vice President Technical Communication & Regulatory Strategy, Pall BiotechWhat is the current state of acceptance of single-use technologies in the pharmaceutical industry? In your opinion have they become “mainstream”? Click Here For Complete Abstract Text
|
||||||||||||||||||
Application Sequencing | ||||||||||||||||||
|
||||||||||||||||||
Company | Product | Process | Other Subjects | Event | Event Date | Location | Publication | Publication Date | Text Descriptor | |||||||||
|
|
|
|
|
|
|